RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026078, 2026. DOI: 10.4084/MJHID.2026.078. Disponível em: https://www.mjhid.org/mjhid/article/view/6454. Acesso em: 1 nov. 2026.